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Epidemiology of diabetes and
complications among adults in
the Republic of Ireland 1998-2015:
a systematic review and meta-analysis
Marsha L. Tracey1*, Michael Gilmartin2, Kate O’Neill1, Anthony P. Fitzgerald1, Sheena M. McHugh1,
Claire M. Buckley1,3, Ronan J. Canavan4 and Patricia M. Kearney1
Abstract
Background: Accurate estimates of the burden of diabetes are essential for future planning and evaluation of services.
In Ireland, there is no diabetes register and prevalence estimates vary. The aim of this review was to systematically
identify and review studies reporting the prevalence of diabetes and complications among adults in Ireland between
1998 and 2015 and to examine trends in prevalence over time.
Methods: A systematic literature search was carried out using PubMed and Embase. Diabetes prevalence estimates
were pooled by random-effects meta-analysis. Poisson regression was carried out using data from four nationally
representative studies to calculate prevalence rates of doctor diagnosed diabetes between 1998 and 2015 and was
also used to assess whether the rate of doctor diagnosed diabetes changed over time.
Results: Fifteen studies (eight diabetes prevalence and seven complication prevalence) were eligible for inclusion. In
adults aged 18 years and over, the national prevalence of doctor diagnosed diabetes significantly increased from 2.2 %
in 1998 to 5.2 % in 2015 (p trend≤ 0.001). The prevalence of diabetes complications ranged widely depending on study
population and methodology used (6.5–25.2 % retinopathy; 3.2–32.0 % neuropathy; 2.5-5.2 % nephropathy).
Conclusions: Between 1998 and 2015, there was a significant increase in the prevalence of doctor diagnosed diabetes
among adults in Ireland. Trends in microvascular and macrovascular complications prevalence could not be examined
due to heterogeneity between studies and the limited availability of data. Reliable baseline data are needed to monitor
improvements in care over time at a national level. A comprehensive national diabetes register is urgently needed in
Ireland.
Keywords: Ireland, Prevalence, Trends, Diabetes, Microvascular, Macrovascular, Adults, Epidemiology
Background
Diabetes is a serious global public health issue which
has been described as the most challenging health
problem in the 21st century [1, 2]. Cases of diabetes
have progressively increased worldwide; between 1980
and 2008 there was a two-fold increase in the number
of adults with diabetes [3]. Type 2 diabetes is the main
driver of the epidemic, accounting for approximately
90 % of all cases [2]. The increasing burden of diabetes
is driven primarily by rising levels of obesity and an
ageing population [2, 4]. To date there is no national
surveillance programme, or national population-based
survey of diabetes in Ireland. Therefore it is difficult to
quantify or monitor the impact of diabetes at a national
level. Estimates from the International Diabetes Feder-
ation (2013) suggest that the prevalence of diabetes is
in line with global trends. In 2000, the IDF estimated
that the prevalence of diabetes was 3.2 % [5], this had
increased to 6.5 % in 2013 [2].
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Diabetes places a significant burden of care on the
individual, health care professionals and the wider health
system [1, 6]. Individuals with diabetes are two to four
times more likely to develop cardiovascular disease
relative to the general population and have a two to
five-fold greater risk of dying from these conditions [7, 8].
Diabetes is a significant cause of blindness in adults, non-
traumatic lower limb amputations and end-stage renal
disease resulting in transplantation and dialysis [2].
Understanding the epidemiology of diabetes is essential
to identify public health priorities. Accurate estimates of
the burden of diabetes are essential for future planning
and evaluation of services. While the IDF provides preva-
lence estimates for countries and regions, there are sub-
stantial variations in time trends as estimates are based on
imputations [9, 10]. To date, estimates of diabetes preva-
lence in Ireland have been largely based on data from the
2007 National Survey of Health and Lifestyles in Ireland
(SLÁN) [11]. Country specific prevalence rates have also
been reported in the grey literature [2]; however these es-
timates have been extrapolated using data from the UK.
The Euro Diabetes Index (2014) stated that there was a
lack of reliable data to monitor diabetes related complica-
tions in Ireland [12]. To date, a comprehensive overview
of the diabetes situation in Ireland has not been carried
out. Therefore the rationale for carrying out this system-
atic review is to provide a comprehensive understanding
of the diabetes situation in Ireland and to highlight
current gaps in existing knowledge to inform future re-
search. The aims of this review are (1) to systematically
identify and summarise studies describing the prevalence
of diabetes and the most common microvascular (retinop-
athy, neuropathy and nephropathy) and macrovascular
complications among adults in Ireland between 1998 and
2014; and (2) to explore trends in diagnosed diabetes
prevalence between 1998 and 2015.
Methods
This review was produced according to Preferred Report-
ing Items for Systematic reviews and Meta-Analyses
(PRISMA) guidelines for systematic reviews and meta-
analyses [13]. Key words and study eligibility criteria were
determined a priori.
Search strategy
Both peer-reviewed journal articles and reports were
considered for this review. A systematic literature search
was carried out in PubMed and Embase databases to
identify relevant studies reporting the prevalence of
diabetes, microvascular or macrovascular complica-
tions among adults within the Republic of Ireland.
Keywords and Medical Subject Headings (MeSH) terms
included Ireland, prevalence, diabetes, microvascular,
retinopathy, neuropathy, nephropathy, macrovascular and
cardiovascular disease. Keywords were combined using
the AND or OR operators (Additional file 1). Titles and
abstracts of the resulting literature were screened for
further consideration. Reference lists of articles were
also examined to identify potentially relevant studies.
In addition, a Google search was conducted using the
keywords prevalence, diabetes, retinopathy, neuropathy,
nephropathy and Ireland to identify relevant grey litera-
ture. Searches were carried out between January 2014
and March 2014. A second search was carried out in
December 2015 to ensure the review included all up to
date relevant information.
Inclusion criteria
Studies were eligible for inclusion if they met the follow-
ing criteria: (1) conducted in the Republic of Ireland
between 1998 and 2014; (2) cross-sectional study design
or baseline data from longitudinal studies; (3) prevalence
estimates reported for adults aged ≥ 18 years, including
men and women; (4) data provided on diabetes prevalence
(including a self-report of a previous doctor diagnosis and
undiagnosed diabetes) and/or the prevalence of micro-
vascular complications (retinopathy, neuropathy, nephropa-
thy) or macrovascular complications (myocardial infarction,
congestive heart failure, stroke or TIA) in persons with
diabetes; (5) if prevalence data were not reported, sufficient
detail to calculate the numerator and denominator was
provided; (6) the total sample size was ≥ 200; (7) adequate
information was reported on the methods used.
Exclusion criteria
Studies containing participants from Northern Ireland,
restricted to a specific sub-population (including hospital-
based studies), solely focused on type 1 diabetes, pre-
diabetes or gestational diabetes were excluded from this
review. Model estimates of prevalence were also excluded.
If multiple articles provided information on a single study,
the article detailing the most comprehensive data was
selected. Full text articles were retrieved for all potentially
eligible studies and were independently reviewed by three
authors (MT, MG, and KON).
Data abstraction and quality assessment
For each eligible study, three reviewers (MT, MG, and
KON) individually collected relevant information using a
structured data extraction form. The methodological
quality of each included study was assessed using a critical
appraisal checklist for studies used in systematic reviews
addressing questions of prevalence [14]. This appraisal
tool was developed to specifically examine the internal
and external validity of prevalence data included in sys-
tematic reviews. Methodological quality was considered
‘low’ if three or less criteria were met, ‘moderate’ if four to
six criteria were met and ‘high’ if seven to nine criteria
Tracey et al. BMC Public Health  (2016) 16:132 Page 2 of 13
were met. Articles were not excluded on the basis of
quality. Any inconsistencies in data abstraction and
quality assessment between reviewers were resolved
through consensus.
Statistical analysis
A meta-analysis was carried out using STATA version
13.1 (StataCorp, College Station, TX, USA). Studies
were grouped into four categories: diagnosed diabetes
among adults aged 18+ years; diagnosed and undiag-
nosed diabetes among adults aged 45+ years; diagnosed
diabetes among adults aged 45+ years; undiagnosed
diabetes among adults aged 45+ years. Pooled estimates
of diabetes prevalence and 95 % confidence intervals
(95 % CI) were calculated. Trends in pooled prevalence
could not be explored as there was a lack of available
data from different time points; therefore an overall
estimate was provided for each group. Heterogeneity
between studies was assessed by the Chi-square based
Q test and I2 statistic. Potential publication bias was
evaluated by the Begg’s test. A two-tailed p <0.05 was
regarded to be statistically significant. High heterogen-
eity was found among studies reporting diabetes preva-
lence (I2 ≥ 75 %, p-value < 0.01) hence, pooled estimates
were calculated using random-effects model using the
method of DerSimonian and Laird [15]. The results
from the meta-analysis were presented in a forest plot.
To determine the robustness of the results, a sensitivity
analysis, based on high quality studies, was carried out.
A meta-analysis of the prevalence of diabetes complica-
tions was inappropriate; factors which influence preva-
lence estimates (e.g. time since diabetes diagnosis, type
of diabetes, method of diagnosis) either varied between
studies or were not reported. Instead a narrative synthesis
provides a summary of relevant data.
Trends in diagnosed diabetes
As trends in diabetes prevalence could not be calculated
by meta-analysis, original datasets from four national
population based studies [16–19], identified during the
literature search were obtained and analysed. In each
dataset, diabetes was defined by a self-report of a previous
doctor diagnosis. A detailed description on study method-
ology can be found elsewhere [18, 20]. Using data from
these national surveys, multivariate Poisson regression
models were undertaken to impute annual gender and
age-specific (18–39 years, 40–69 years, ≥70 years) rates of
diagnosed diabetes and to assess trends over time. The
dependent variable was the number of cases of diagnosed
diabetes and the exposure variables were year of data
collection and age group. An interaction term between
calendar year and age group was considered to explore
whether the rates of change over time differed across age
groups; a non-significant interaction indicated a common
linear trend in prevalence. The predict command was
used post analysis to calculate the expected rates of diag-
nosed diabetes for each calendar year of the study. The
gender and age-specific predicted rates were applied to
2004–2015 population data so the absolute number of
diabetes cases could be obtained. Annual population esti-
mates were obtained from the Central Statistics Office
(CSO), Ireland [21]. A census took place in Ireland in
2002, 2006 and 2011; data for other study years were CSO
inter-censal estimates [21]. Prevalence was calculated by
dividing the number of expected cases of doctor diagnosis
of diabetes by the total study population and was expressed
as a percentage with 95 % CI. Prevalence estimates were
presented graphically in Excel.
Results
Study selection
Results of the literature search and the selection process
are summarised in Fig. 1. One report [22] provided two
estimates for diabetes prevalence from two separate
studies [16, 17]. In total, 15 studies were eligible for
inclusion; eight reporting estimates on diabetes preva-
lence and seven reporting estimates on complication
prevalence. Of the included studies, the methodological
quality was considered moderate in nine studies and
high in the remaining studies (Additional file 2).
Characteristics of selected studies
Characteristics of studies that reported the prevalence
of diabetes or diabetes complications are presented in
Tables 1 and 2. In all included studies, data collection
were carried out between 1998 and 2011. Studies varied in
terms of the study design, setting (national vs. regional),
sampling approach and study quality. Of the 8 studies
reporting on diabetes prevalence (Table 1), five articles
had been published in peer-reviewed journals [11, 23–26],
while three estimates were reported in two national re-
ports [22, 27]. Of the 7 studies reporting diabetes com-
plications (Table 2), six had been published in peer-
reviewed journals [28–33], while one audit [34] pro-
vided data on the prevalence of diabetes related complica-
tions. Five studies utilised an objective data source to
ascertain the prevalence of complications [28–30, 33, 34].
The diagnostic criteria for complications was unclear in
three studies [31, 31, 34] whereas the remaining four
used validated diagnostic criteria to identify cases
[28–30, 33], however these criteria differed between
studies reporting on the same complication.
Prevalence of diabetes in included studies
Table 3 reports the prevalence of diabetes by study. Indi-
vidual and summary estimates, based on a random-effects
meta-analysis are illustrated in Fig. 2. There was signifi-
cant heterogeneity in all groups. Sensitivity analysis only
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showed lower heterogeneity in combined prevalence rates
for undiagnosed and diagnosed diabetes among adults
aged over 45 years (I2 ≥ 25 %, p = 0.36); with a pooled
prevalence of 9.2 % (95 % CI: 8.6–9.8) (Additional file 3).
According to the Egger’s test, there was no evidence of
publication bias (p = 0.27).
Trends in the prevalence of diagnosed diabetes over time
In adults aged 18 years and over, the prevalence of diag-
nosed diabetes increased from 2.2 % (95 % CI: 1.7 %–
2.7 %) in 1998 to 5.2 % (95 % CI: 5.1 %–5.3 %) in 2015
(ptrend = <0.001); representing an absolute mean increase
of 0.17 % per year. In 2015, the incidence of diagnosed
diabetes was 0.2/100 population.
Figure 3 illustrates the age-specific prevalence of self-
reported diagnosed diabetes from 1998 to 2015. In adults
aged between 18 and 39 years, the prevalence of self-
reported doctor diagnosed diabetes remained stable
between 1998 and 2015 in both men and women;
ptrend >0.05. However, there was a significant increase in
Fig. 1 PRISMA flow chart depicting the selection process of articles included in the systematic review
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Table 1 Characteristics of studies reporting the prevalence of diabetes or related complications among adults in the Republic of Ireland, 1998–2011
Author Year of data
collection
Study design National or
regional
Setting Population Sampling frame Sampling method Sample size Males
(%)
Age
(years)
Study quality
(out of 9)
Diabetes prevalence
Sheily and
Kelleher [22]
1998 Cross-sectional National Household General population Electoral register Multistage sample 1632 47.7 55 7
Creagh
et al. [23]
1998 Cross-sectional Regional 17 GP practices Primary Care Patients Practice list Stratified random 1018 48.2 50–69 6
Census Statistic
Office (CSO) [27]
2001 Survey National Household General population Census Total sample 3917203 - 18 5
Sheily and
Kelleher [22]
2002 Cross-sectional National Household General population Electoral register Multistage sample 1745 41.7 55 7
Balanda
et al. [11]
2007 Cross-sectional National Household General population Geodirectory Multistage probability 10,364 49.5 18 8
Gallagher
et al. [24]
2009-2010 Cross-sectional National Database Patients covered by
GMS, LTI, DPS schemes
HSE-PCRS pharmacy
claims data base
Total sample
2009
2010
3493974
3490877
- 16 6
Leahy et al. [25] 2009-2011 Cross-sectional
analysis of
longitudinal
study
National Household &
designated
health centre
General population Geodirectory Multi-stage probability 5377 46.5 50 8
OConnor
et al. [26]
2010-2011 Cross-sectional Regional Primary care centre Patients Practice list Random 2047 49.2 50–69 8
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Table 2 Characteristics of studies reporting the prevalence of diabetes or complications among adults in the Republic of Ireland, 1998-2011
Author Year of data
collection
Study design National or
regional
Setting Population Sampling frame Sampling method Sample
size
Males
(%)
Age
(years)
Study quality
(out of 9)
Complication
prevalence
Kelliher
et al. [28]
2003 Cross-sectional National National Council
for Blind Ireland
(NCBI)
All person registered
blind
NCBI database Total sample 6826 - Adults 8
Buckley
et al. [29]
2009 Cross-sectional National Population People with diabetes Hospital In-Patient
Enquiry (HIPE) dataset
Total sample 723551 - 20 years 9
Marsden
et al. [34]
2008-2009 Audit Regional 20 general
practices
Patients with T1 & T2 DM
registered with diabetes
structure care programme
Practice patient list Every second
person from list
1071 51.9 63 (sd
13)
5
Hurley
et al. [30]
2008-2009 Cross-sectional
analysis of
longitudinal study
Regional General
practices with
diabetes nurse
Patients with T1 & T2 DM Practice diabetes
register
Researchers selected
eligible participants
563 60 64 (sd
13.4)
6
Farrell &
Moran [31]
2010 Cross-sectional Regional 30 general
practices
T2 DM Diabetes imitative
database
Stratified sampling 309 - - 5
Tracey
et al. [32]
2009-2011 Cross-sectional
analysis of
longitudinal study
National Household General population Geodirectory Multi-stage
probability
8175 53 50 8
McHugh
et al. [33]
2011 Cross-sectional Regional 30 general
practices
Patients with T1 & T2 DM Practice patient list All persons with
T1&T2DM invited
1542 57.3 65 (sd
13)
7
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Table 3 Prevalence of diabetes among adults in included studies, 1998-2011
Study Year of data
collection
Response
rate (%)
Sample size Age Diabetes
type
Diagnostic criteria Estimate Prevalence % (95 % CI)
Males Females Total
Sheily and
Kelleher [22]
1998 62 1632 55 years All SRa Diagnosed 6.1 4.3 5.4
Creagh et al. [23] 1998 69.1 1018 50–69 years 2 FPGb Diagnosed
Undiagnosed
Total
Total 65 years
-
-
-
13
-
-
-
7
2.8
1.2
3.9 (2.9–5.4)
-
CSO [27] July- Sept. 2001 - 3917203 18 years All SR Diagnosed
18 years
65 years
-
1.7
-
1.4
1.5
4.5
Sheily and
Kelleher [22]
2002 53 1745 55 years All SR Diagnosed 8.0 5.1 6.4
Balanda et al. [11] 2007 62 10,364 18 years All SR or medication use
or HbA1cc
Diagnosed
18–44 years
45+ years
Total 18 years
Undiagnosed ( 45 years)
Total (diagnosed & undiagnosed
45 years)
-
6.8 (5.7–7.9)
-
4.0 (1.6–6.3)
10.8 (8.2–13.4)
-
5.4 (4.3–6.6)
-
1.7 (0.3–3.0)
7.1 (5.3–8.9)
0.7 (0.5–0.9)
6.1 (5.5–6.9)
3.5 (3.1–3.9)
2.8 (1.4–4.1)
8.9 (7.3–10.5)
Gallagher et al.
[24]
2009
2010
- 3493974
3490877
18 years 2 At least 1 prescription
of diabetes medication
Diagnosed
2009
2010
-
-
-
-
2.8
3.1
Leahy et al. [25] 2009–2011 62 5377 50 years 2 SR or medication use
or HbA1cc
Diagnosed
Undiagnosed
Total (diagnosed & undiagnosed)
50–59 years
60–69 years
70–79 years
80+ years
-
-
11.8 (10.3–13.3)*
5.1 (4.0–7.0)
6.0 (5.0–8.0)
12.0 (8.0–14.0)
10.0 (5.0–15.0)
-
-
7.3 (6.0–8.5)*
4.0
14.0 (11.0–16.0)
17.0 (14.0–21.0)
25.0 (15.0–36.0)
8.6 (7.6–9.5)
0.9 (0.6–1.1)
9.5 (8.5–10.4)
5.0 (4.0–6.0)
-
-
16.0 (10.7–21.4)
OConnor et al.
[26]
2010-2011 67.9 2047 50–69 years 2 SR or medication use
or HbA1cc
Diagnosed
Undiagnosed
Total
6.8*
7.1*
11.1*
3.1*
2.7*
6.0*
5.0 (4.1–6.0)
3.5 (2.8–4.4)
8.5 (7.4–8.8)
*p for difference < 0.05
aSR self-reported data; bFasting plasma glucose (American Diabetes Association criteria (ADA, 1997); cHbA1c (ADA, 2010)
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prevalence among men aged 40 to 69 years between 1998
(3.5 % [95 % CI: 3.4–3.6 %]) and 2015 (6.6 % [95 % CI:
6.5–6.7 %]; ptrend <0.001). The prevalence of diabetes
also increased among women in the same age group
over the same time period (1998–2.5 % [95 % CI: 2.4–
2.5 %] to 2015- 4.2 % [95 % CI: 4.1–4.3 %]; ptrend
<0.001). In those aged 70 years and over, an upward
trend in prevalence among both men (1998–8.2 %
[95 % CI: 8.0–8.3 %] to 2015- 15.1 % [95 % CI: 14.8–
15.2 %]) and women (1998- 4.7 % [95 % CI: 4.5–4.8 %]
Fig. 2 Forest plot of individual and summary diabetes prevalence estimates of included studies
Fig. 3 Prevalence of self-reported doctor diagnosed diabetes among adults in RoI, 1998–2015
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to 2015- 10.7 % [95 % CI: 10.5–10.8 %]) was also observed;
ptrend <0.001.
Prevalence of microvascular and macrovascular
complications
Table 4 describes the prevalence of microvascular and
macrovascular complications in each included study.
Five out of seven studies reported the prevalence of retin-
opathy [27, 29–31, 33]. Among people with type 2 dia-
betes, a population based study reported the prevalence of
diabetic retinopathy to be 8.5 % in 2009–2011 [30]; a
regional study, carried out among primary care patients,
found a higher prevalence of 24.8 % [31]; however this
estimate included patients with type 1 and 2 diabetes and
was based on objective data. A similar estimate (25.6 %)
was reported in a comparable cohort of primary care
patients in a different region [33].
In terms of diabetes-related neuropathy, a divergence
in the reported prevalence between studies was also ob-
served. Data from 12 primary care centres in the West of
Ireland indicated a prevalence of past documented neur-
opathy to be 3 % [30]. On the other hand, a population-
based study reported a prevalence of 14.6 % [32]. These pa-
tients had similar average duration since diagnosis (7.8 years
[30] vs. 5.0 years [32]); however, the latter estimate was
based on self-reported data. Prevalence rates for leg
amputations were 1.7 % among primary care patients
with diabetes [30]. In contrast, the prevalence of non-
traumatic lower leg amputation was lower (0.2 %) in a
population-based study which utilised national hospital
discharge data [29].
With reference to nephropathy, prevalence among those
with type 2 diabetes was similar in two studies [31, 32]. In
the three studies presenting data on macrovascular compli-
cations, a marked difference in prevalence was observed. A
primary care audit reported a prevalence of 3.5 % in pa-
tients with type 1 and 2 diabetes [34]. In contrast, among
those with type 2 diabetes, a population based study re-
ported a higher prevalence of 15.1 % [32].
Discussion
This systematic review is the first study to compile all
available evidence reporting the prevalence of diabetes
(diagnosed and undiagnosed) and related complications
(microvascular and macrovascular) among adults in
Ireland between 1998 and 2015. Fifteen studies (eight
describing diabetes prevalence and seven describing
complication prevalence) were included.
Similar to other systematic reviews [35–37]; compar-
ability between studies was limited due to differences in
study population, sampling methods and diagnostic cri-
teria. Additionally, substantial statistical heterogeneity was
detected between studies reporting the prevalence of dia-
betes; therefore our pooled estimates have to be interpreted
with caution. Sensitivity analysis, based on study quality,
lowered the heterogeneity of combined prevalence rates
for undiagnosed and diagnosed diabetes among adults aged
over 45 years. However, this may reflect variability between
prevalence estimates rather than study quality. Trends
in diabetes prevalence could not be explored by meta-
analysis, therefore, original data from four population-
based national studies [16–19] were obtained to explore
time trends in doctor diagnosed diabetes prevalence
between 1998 and 2015. Over a seventeen year period,
we observed an important increase in the national preva-
lence of self-reported diagnosed diabetes in Ireland.
Consistent with previous research [38–40] trends in the
prevalence of self-reported diagnosed diabetes remained
constant in adults aged 18 to 39 years, while an increasing
prevalence was observed in the older age groups. We were
unable to distinguish between the various types of diabetes
in this review; however it can be assumed that type 2 dia-
betes is driving the increase in prevalence as it accounts
for 90 % of all diabetes cases [1, 2]. The prevalence of
diabetes was consistently higher in males compared to
females. Evidence suggests that men are at a higher risk of
developing type 2 diabetes as they develop diabetes at a
lower BMI, are more predisposed to central fat deposition
and are more prone to insulin resistance [41]. Therefore,
men are more likely to develop type 2 diabetes in response
to increasing levels of obesity [42]. On the other hand, the
higher prevalence in the male population may reflect pref-
erences in diagnostic methods. Evidence has highlighted
that the prevalence of FPG diagnosed diabetes is higher
among men, whereas women are more commonly diag-
nosed by a 2-h plasma glucose test [43]. While it is not
possible to determine the method of diabetes diagnosis in
this review; it is important to consider how these gender
differences may influence diagnosed diabetes prevalence
estimates over time.
Similar to diagnosed diabetes, trends in the prevalence
of undiagnosed diabetes could not be explored by meta-
analysis as only two nationally representative studies had
relevant data [11, 25]. The prevalence of undiagnosed
diabetes, based on HbA1c, decreased from 2.8 % in 2007
to 0.9 % in 2009–2011 among adults aged ≥45 years and
≥50 years, respectively. While the prevalence of diag-
nosed diabetes increased from 6.1 % in 2007 [11] to
8.6 % in 2009–2011 [25]. This shift from undiagnosed to
diagnosed diabetes prevalence has also been observed in
a study carried out in Germany [10]. This decrease in
undiagnosed diabetes prevalence may be attributable to
earlier detection of diabetes [10]. In Ireland, screening
high risk patients for type 2 diabetes has been encouraged
since the introduction of national guidelines for diabetes-
care in 2002 [44]. Another study based on 29144 adults
aged 45–75 years with private health insurance, reported
the prevalence of undiagnosed diabetes to be 1.8 % in
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Table 4 Prevalence of microvascular and macrovascular complications in included studies, 2003–2011
Author Year of
study
Response
rate (%)
Sample
size
Age Diabetes
type
Time since
diabetes
diagnosis
Data source Diagnostic method Type of complication Prevalence (%)
Total
Kelliher
et al. [28]
2003 - 6826 Adults All - National blind registry Visual acuity of <6/60 in
better eye/visual field
subtending angle of
20°/< less
Blindness due to diabetic retinopathy 4.7
Buckley
et al. [29]
2009 - 723,551 20 years All - Hospital discharge
data
ICD-10 codes Non-traumatic lower leg amputation 0.2
Marsden
et al. [34]
Nov 2008-
March 2009
72 1071 63 years
(sd 13)
T1: 7.5 %
T2: 92.3 %
15 years Electronic & paper
clinical notes & referral
letters
-
Risk classification score
ACR 2.5–25
ACR >25
-
-
-
-
Diabetic retinopathy
Foot ulcer
Microalbuminuria
Proteinuria
Myocardial Infarction
Heart Failure
Transient Ischemic Attack
Stroke
Total macrovascular
24.8
2.5
32.1
6.0
0.4
0.3
1.5
0.5
3.5
Hurley
et al. [30]
Feb 2008-
Sept 2009
68 563 64 years
(sd 13.4)
T1: 10 %
T2: 90 %
7.7 (8.2)
years
Clinical foot examination
& practice medical records
Scottish Intercollegiate
Guidelines Network risk
stratificationsystem &
previous doctor diagnosis
Documented diabetic neuropathy
Foot ulceration
Past amputation
Neuropathy symptoms at examination
3.0
3.7
1.7
32
Farrell &
Moran [31]
2010 - 309 - T2 - Chart review - Diabetic retinopathy
Neuropathy
Peripheral vascular disease
Chronic kidney disease
Cerebrovascular disease
6.5
12.3
12.9
5.5
5.2
Tracey
et al. [32]
2009–2011 62 655 50 years T2 5 (IQR 3–10)
years
SR previous doctor
diagnosis
- Diabetic retinopathy
Neuropathy
Leg ulcer
Nephropathy
Proteinuria
Total macrovascular
8.2 (6.2–10.9)
14.6 (11.4–18.2)
4.2 (2.8–6.4)
5.1 (3.4–7.6)
6.1 (4.3–8.6)
15.1 (12.2–18.4)
McHugh
et al. [33]
2011 GP = 94 %;
Screening
uptake = 43 %
1542 65 years
(sd 13)
T1: 4.9 %
T2: 85.6 %
- Eye examination & clinical
records
Fundus 45° digital
PASA-approved camera
Background (R1)
Pre proliferative (R2)
Proliferative (R3)
Any diabetic retinopathy
21.5 (19.5–23.6)
3.4 (2.6–4.5)
0.7 (0.4–1.3)
25.6 (23.5–27.9)
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al.BM
C
Public
H
ealth
 (2016) 16:132 
Page
10
of
13
2009–2012 [45]. However this estimate was derived from
FPG; evidence suggests that the use of HbA1c may under-
estimate diabetes prevalence compared with estimates
using FPG [38, 43, 46].
The prevalence of diabetes complications varied substan-
tially between studies therefore comparisons between stud-
ies have to be interpreted with caution. These variations
may be attributable to differences in disease duration or
study population (type 1 and type 2 diabetes vs. type 2 dia-
betes), study setting (primary care vs. population-based) or
heterogeneity in the criteria used to diagnose macrovascu-
lar and microvascular complications. Objective data de-
scribing the national prevalence of diabetic retinopathy
was not available however, regional data on diabetic retin-
opathy showed that approximately 25 % of primary care
patients with type 1 and type 2 diabetes had been diag-
nosed with this condition [33, 34]. This estimate is higher
than a previous hospital-based study based on patients
with type 2 diabetes (14.8 %) [47] and primary care data
from the UK (19.6 %) [48] but lower than global prevalence
estimates (34.6 %) [49]. Though, caution has to be applied
when interpreting the results as both regional studies in-
cluded in this review reported a low uptake rate of retinop-
athy screening at approximately 50 % [33, 34].
Additionally, characteristics between attenders and non-
attenders were not compared in either study; hence it is
possible that there were systematic differences between
the two groups. Healthier people are more likely to par-
ticipate in research; therefore the prevalence of diabetic
retinopathy may have been underestimated. As a na-
tional screening programme for diabetic retinopathy
was introduced in 2013 [50], future estimates based on
this national programme may be more reliable.
Limitations
The strengths and limitations of this systematic review
should be noted. Both peer-reviewed articles and esti-
mates detailed in the grey literature were included to limit
the impact of publication bias. Original data from four
national studies were obtained so trends in diagnosed
diabetes prevalence could be examined over a 17 year
period. Although response rates were below the optimal
rate of 70 %, the representativeness of each study has
been demonstrated previously [18, 51], so it can be
assumed that the results presented can be generalised
to the Irish population.
However, several limitations need to be acknowledged.
Firstly, studies included in this review were of moderate
to high quality; however, six of the included studies relied
on self-reporting to determine the prevalence of diagnosed
diabetes and one study relied on self-reporting to deter-
mine the prevalence of diabetes related complications.
This approach is prone to misclassification bias which
can result in an inaccurate estimation of prevalence
[52]. When compared to medical records, data from self-
report have been shown to underestimate the prevalence
of diabetic retinopathy [53]. However, moderate to high
levels of agreement between diabetes prevalence and self-
report have been shown in several studies [54–56]. Al-
though only data on self-reported diabetes were available,
results from trend analysis are in line with other developed
countries. Secondly, without the inclusion of undiagnosed
diabetes in our trend analysis, we acknowledge that diabetes
prevalence is underestimated. Finally, significant increases
in diagnosed diabetes prevalence were observed over time
but these increases may be attributed to heightened aware-
ness among patients, changes in clinical practices, including
increased screening for type 2 diabetes, and better survival
rates for patients with diabetes [57]. However, there is a
lack of data on mortality rates among people with diabetes
in Ireland; therefore it is not possible to determine whether
our increasing trends in prevalence are due to improved
health outcomes in those with diabetes.
Conclusion
This review provides the first comprehensive overview
of the burden of diabetes in Ireland. In the absence of a
national diabetes register, the findings in this review pro-
vide a robust estimate of the trends in prevalence of
doctor diagnosed diabetes among the adult population
in Ireland. Findings from this review are in accordance
with the Euro Diabetes Index (2014) [12]; there is a lack
of information relating to the prevalence of undiagnosed
diabetes, macrovascular and microvascular complications.
Interpretation of available data was limited due to incon-
sistencies in reporting, limited availability of objective data
and standardisation in diagnostic criteria. We suggest that
the true burden of diabetes in Ireland is underestimated
[58]. In 2010, the National Clinical Programme in Dia-
betes was established to improve and standardise patient
care in Ireland [59]. Reliable baseline data are needed to
monitor improvements in care over time at a national
level. Therefore, we suggest that a comprehensive national
diabetes register is urgently needed in Ireland.
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